63 related articles for article (PubMed ID: 31538243)
21. Nonhuman primate model of persistent erectile and urinary dysfunction following radical prostatectomy: Feasibility of minimally invasive therapy.
Zambon JP; Patel M; Hemal A; Badlani G; Andersson KE; Magalhaes RS; Lankford S; Dean A; Williams JK
Neurourol Urodyn; 2018 Sep; 37(7):2141-2150. PubMed ID: 30168617
[TBL] [Abstract][Full Text] [Related]
22. Functional outcomes of robot-assisted radical prostatectomy in patients eligible for active surveillance.
Zanaty M; Ajib K; Zorn K; El-Hakim A
World J Urol; 2018 Sep; 36(9):1391-1397. PubMed ID: 29680952
[TBL] [Abstract][Full Text] [Related]
23. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.
Sanda MG; Cadeddu JA; Kirkby E; Chen RC; Crispino T; Fontanarosa J; Freedland SJ; Greene K; Klotz LH; Makarov DV; Nelson JB; Rodrigues G; Sandler HM; Taplin ME; Treadwell JR
J Urol; 2018 Mar; 199(3):683-690. PubMed ID: 29203269
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Approach to Port Placement Templates for Robot-Assisted Laparoscopic Urologic Surgeries.
Pathak RA; Patel M; Hemal AK
J Endourol; 2017 Dec; 31(12):1269-1276. PubMed ID: 28967280
[TBL] [Abstract][Full Text] [Related]
25. Functional Outcomes Following Nerve Sparing Prostatectomy Augmented with Seminal Vesicle Sparing Compared to Standard Nerve Sparing Prostatectomy: Results from a Randomized Controlled Trial.
Gilbert SM; Dunn RL; Miller DC; Montgomery JS; Skolarus TA; Weizer AZ; Wood DP; Hollenbeck BK
J Urol; 2017 Sep; 198(3):600-607. PubMed ID: 28392393
[TBL] [Abstract][Full Text] [Related]
26. Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes.
Villers A; Puech P; Flamand V; Haber GP; Desai MM; Crouzet S; Leroy X; Chopra S; Lemaitre L; Ouzzane A; Gill IS
Eur Urol; 2017 Sep; 72(3):333-342. PubMed ID: 27613061
[TBL] [Abstract][Full Text] [Related]
27. Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience.
Musunuru HB; Yamamoto T; Klotz L; Ghanem G; Mamedov A; Sethukavalan P; Jethava V; Jain S; Zhang L; Vesprini D; Loblaw A
J Urol; 2016 Dec; 196(6):1651-1658. PubMed ID: 27569437
[TBL] [Abstract][Full Text] [Related]
28. Holmium laser enucleation of the prostate followed by high-intensity focused ultrasound treatment for patients with huge prostate adenoma and localized prostate cancer: 5-Year follow-up.
Horiuchi A; Muto S; Horie S
Prostate Int; 2016 Jun; 4(2):49-53. PubMed ID: 27358843
[TBL] [Abstract][Full Text] [Related]
29. Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial.
Godtman RA; Holmberg E; Khatami A; Pihl CG; Stranne J; Hugosson J
Eur Urol; 2016 Nov; 70(5):760-766. PubMed ID: 27090975
[TBL] [Abstract][Full Text] [Related]
30. The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer.
Tan HJ; Marks LS; Hoyt MA; Kwan L; Filson CP; Macairan M; Lieu P; Litwin MS; Stanton AL
J Urol; 2016 Jun; 195(6):1724-30. PubMed ID: 26872841
[TBL] [Abstract][Full Text] [Related]
31. Site-dependent and interindividual variations in Denonvilliers' fascia: a histological study using donated elderly male cadavers.
Muraoka K; Hinata N; Morizane S; Honda M; Sejima T; Murakami G; Tewari AK; Takenaka A
BMC Urol; 2015 May; 15():42. PubMed ID: 25962380
[TBL] [Abstract][Full Text] [Related]
32. Robot-assisted laparoscopic simple anatomic prostatectomy.
Patel MN; Hemal AK
Urol Clin North Am; 2014 Nov; 41(4):485-92. PubMed ID: 25306160
[TBL] [Abstract][Full Text] [Related]
33. Robot-assisted radical prostatectomy: inching toward gold standard.
Sood A; Jeong W; Peabody JO; Hemal AK; Menon M
Urol Clin North Am; 2014 Nov; 41(4):473-84. PubMed ID: 25306159
[TBL] [Abstract][Full Text] [Related]
34. Denonvilliers' fascia revisited.
Kim JH; Kinugasa Y; Hwang SE; Murakami G; Rodríguez-Vázquez JF; Cho BH
Surg Radiol Anat; 2015 Mar; 37(2):187-97. PubMed ID: 25008480
[TBL] [Abstract][Full Text] [Related]
35. Incidental prostate cancer in transurethral resection of the prostate specimens in the modern era.
Otto B; Barbieri C; Lee R; Te AE; Kaplan SA; Robinson B; Chughtai B
Adv Urol; 2014; 2014():627290. PubMed ID: 24876835
[TBL] [Abstract][Full Text] [Related]
36. Significance of prostate-specific antigen-related factors in incidental prostate cancer treated by holmium laser enucleation of the prostate.
Otsubo S; Yokomizo A; Mochida O; Shiota M; Tatsugami K; Inokuchi J; Naito S
World J Urol; 2015 Mar; 33(3):329-33. PubMed ID: 24804843
[TBL] [Abstract][Full Text] [Related]
37. Holmium laser enucleation of the prostate and perioperative diagnosis of prostate cancer: an outcomes analysis.
Rivera ME; Frank I; Viers BR; Rangel LJ; Krambeck AE
J Endourol; 2014 Jun; 28(6):699-703. PubMed ID: 24484284
[TBL] [Abstract][Full Text] [Related]
38. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
[TBL] [Abstract][Full Text] [Related]
39. Multifocal prostate cancer: biologic, prognostic, and therapeutic implications.
Andreoiu M; Cheng L
Hum Pathol; 2010 Jun; 41(6):781-93. PubMed ID: 20466122
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of transvesical prostatectomy versus transurethral resection of the prostate for prostate greater than 80 mL.
Ou R; You M; Tang P; Chen H; Deng X; Xie K
Urology; 2010 Oct; 76(4):958-61. PubMed ID: 20394966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
